Business
Rare Disease Therapeutics Market to Surpass US$ 495.27 Billion by 2033 as Gene Therapy, RNA-based Drugs, and Biologics Transform Patient Care
The Rare Disease Therapeutics Market is experiencing an unprecedented wave of innovation, driven by gene therapies, RNA-based treatments, enzyme replacement therapies (ERTs), and targeted biologics. According to DataM Intelligence, the Rare Disease Therapeutics Market Size reached US$ 135.88 billion in 2023, rose to US$ 154.64 billion in 2024, and is projected to reach US$ 495.27 billion by 2033, expanding at a CAGR of 13.8% during 2025–2033.
About this update from Takeda Pharmaceutical Co. Ltd.
[{"type":"text","content":"HYDERABAD, India, Oct. 7, 2025 /PRNewswire/ -- The Rare Disease Therapeutics Market is experiencing an unprecedented wave of innovation, driven by gene therapies, RNA-based treatments, enzyme replacement therapies (ERTs), and targeted biologics. According to DataM Intelligence, the Rare Disease Therapeutics Market Size reached US$ 135.88 billion in 2023, rose to US$ 154.64 billion in 2024, and is projected to reach US$ 495.27 billion by 2033, expanding at a CAGR of 13.8% during 2025–2033.","length":498,"tagName":"p"},{"type":"image","alt":"DataM Intelligence Logo","displaySize":"","headline":null,"caption":"DataM Intelligence Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/d8629f10a81077edae7ba074dc4e4acd"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/nG.P2cl8s5cqOxbtvsLrwA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/d8629f10a81077edae7ba074dc4e4acd","width":400,"height":400}}},{"type":"text","content":"Rare diseases affect over 400 million people worldwide, yet fewer than 10% of conditions have approved therapies. The market's exponential growth is being fueled by the pharmaceutical industry's pivot towards precision medicine, orphan drug incentives, and breakthrough approvals of advanced therapeutics.","length":313,"tagName":"p"},{"type":"text","content":"Global leaders such as Roche, Novartis, Pfizer, Takeda, Sanofi, and Biogen are spearheading innovation pipelines, while emerging biotech companies are leveraging RNA technologies, CRISPR-based gene editing, and monoclonal antibodies to address unmet needs.","length":256,"tagName":"p"},{"type":"text","content":"Download Exclusive Sample Report: https://www.datamintelligence.com/download-sample/rare-disease-therapeutics-market ","length":119,"tagName":"p"},{"type":"text","content":"Browse in-depth TOC on "Rare Disease Therapeutics Market" ","length":67,"tagName":"p"},{"type":"text","content":"70 – Tables66 – Figures195 – Pages","length":36,"tagName":"p"},{"type":"text","content":"Market Segmentation Insights","length":28,"tagName":"p"},{"type":"text","content":"By Therapy Type","length":15,"tagName":"p"},{"type":"text","content":"Enzyme Replacement Therapy (ERT) generated over US$ 46 billion in 2024, d...